Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
88 studies found for:    Open Studies | "Pulmonary Embolism"
Show Display Options
Rank Status Study
21 Unknown  Factor XIII and Pulmonary Embolism in Neurosurgical Patients
Conditions: Brain Tumor;   Vascular Lesion;   Factor XIII Deficiency;   Pulmonary Embolism
Intervention:
22 Recruiting Clinical Characteristics of Acute Pulmonary Embolism in Chinese Population
Condition: Pulmonary Embolism
Intervention:
23 Unknown  Surfactant Associated Protein - A Novel Marker for the Diagnosis of Pulmonary Embolism
Condition: Pulmonary Embolism
Intervention:
24 Recruiting Prevalence of Pulmonary Embolism in Patients With Syncope
Conditions: Syncope;   Pulmonary Embolism
Intervention: Other: Lung CT or V/Q scanning in patients with a high pre-test clinical probability of PE and/or a positive D-dimer
25 Not yet recruiting The Angel® Catheter Clinical Trial
Conditions: Pulmonary Embolism;   Deep Vein Thrombosis;   Venous Thromboembolism
Intervention: Device: The Angel® Catheter
26 Recruiting Diclofenac for Submassive PE
Condition: Pulmonary Embolism
Interventions: Drug: Diclofenac;   Drug: Placebo
27 Recruiting Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)
Conditions: Pulmonary Embolism;   Thromboembolism;   Thrombosis;   Venous Thrombosis;   Venous Thromboembolism
Interventions: Drug: BAY 59-7939;   Drug: ASA
28 Recruiting Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection
Conditions: Venous Thrombosis;   Pulmonary Embolism;   Lung Neoplasms
Intervention:
29 Recruiting Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification
Conditions: Atrial Fibrillation or Pulmonary Embolism;   Need of Long Term Oral Anticoagulation Therapy (OAT);   Existent Coronary or Valvular Calcification, or Both and Agatston Score > 50 in at Least One Location
Intervention: Drug: Rivaroxaban or Marcumar
30 Unknown  Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism Incidence
Conditions: Pulmonary Disease, Chronic Obstructive;   Disease Exacerbation;   Pulmonary Embolism;   Prothrombin Fragments
Intervention: Other: CT pulmonary angio, blood tests
31 Unknown  Value of Prothrombin Fragment F1+2 in the Diagnosis of Pulmonary Embolism in Patients With Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
Conditions: Chronic Obstructive Pulmonary Disease;   Pulmonary Embolism
Intervention: Other: CT pulmonary angio, blood tests
32 Not yet recruiting Use of Gadolinium in CT Pulmonary Angiography
Condition: Pulmonary Embolism
Intervention: Drug: Gadolinium
33 Recruiting Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation
Conditions: Deep Venous Thrombosis;   Pulmonary Embolism
Intervention: Drug: LMWH
34 Recruiting STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Conditions: Deep Venous Thrombosis;   Pulmonary Embolism;   D-dimer
Intervention:
35 Recruiting Thromboembolic Complications After Pacemaker or Implantable Cardioverter-Defibrillator Procedures
Conditions: Bradyarrhythmias;   Arrhythmias;   Cardiovascular Disease;   Venous Thrombosis;   Pulmonary Embolism
Intervention:
36 Unknown  Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis
Conditions: Venous Thrombosis;   Pulmonary Embolism
Intervention: Drug: Enoxaparin
37 Recruiting Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy
Conditions: Deep Venous Thrombosis;   Pulmonary Embolism
Intervention: Drug: LMWH
38 Recruiting Institutional Registry of Thromboembolic Disease
Conditions: Thromboembolism;   Venous Thromboembolism;   Pulmonary Embolism
Intervention:
39 Recruiting Rosuvastatin Use to Improve the Coagulation Profile in Patients With Venous Thrombosis
Conditions: Deep Vein Thrombosis;   Pulmonary Embolism
Intervention: Drug: Rosuvastatin
40 Recruiting Laparoscopic Bariatric Surgery: Two Regimens of Venous Thromboprophylaxis: Prospective Randomized Study
Conditions: Morbid Obesity;   Pulmonary Embolism
Interventions: Drug: Enoxaparin 40 mg 2 hours before arm;   Drug: Enoxaparin 40 mg 12 hours before arm

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years